Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; BoNTA; botulinum toxin type A; RANKL; receptor activator of nuclear factor-κB ligand; Atrogin-1/MAFbx; Atrogin-1/Muscle atrophy F-box; MuRF-1; muscle RING finger 1; Myo; myogenin; Cav3; caveolin-3; B.Ar/T.Ar; bone per tissue area; Tb.Th; trabecular thick
مقالات ISI گیرنده گیرنده لیگاند فاکتور هسته ای κB (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; BMD; bone mineral density; DKK; dickkopf; GWASs; genome-wide association studies; IOF; International Osteoporosis Foundation; IRDiRC; International Rare Diseases Research Consortium; ISDS; International Skeletal Dysplasia Society; OMIM; Online Mendelian I
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; MNCs; multinucleated cells; TRAP; tartrate-resistant acid phosphatase; RANKL; receptor activator of nuclear factor-κB ligand; M-CSF; macrophage colony stimulating factor; OPG; osteoprotegerin; c-fms; colony-stimulating factor-1 receptor; ERK; extracellul
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; RANKL; receptor activator of nuclear factor-κB ligand; OPG; osteoprotegerin; P. gingivalis-LPS; Porphyromonas gingivalis-lipopolysaccharide; Titanium ion; RANKL; OPG; Peri-implantitis;
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; AAS; atomic absorption spectrometry; ALP; alkaline phosphatase; AMP; Aronia melanocarpa polyphenols; AW; bone ash weight (mineral components weight); b-ALP; alkaline phosphatase in the bone tissue; BMD; bone mineral density; Ca; calcium; Ca/AW; the ratio
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; AA; arachidonic acid; aP2 (or FABP4); adipocyte protein 2; BMD; bone mass density; BMP-2; bone morphogenic protein-2; CE; cholesterol esters; CHL; cholesterol; cAMP; cyclic 3,5-adenosine monophosphate; CLA; conjugated isomers of linoleic acid; COX; cycloo
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; CA; carbonic anhydrase; RANKL; receptor activator of nuclear factor-κB ligand; Smac; second mitochondrial-derived activator of caspase; TRAP; tartrate-resistant acid phosphatase; Phloretin; Osteoclast apoptosis; Estrogen deficiency; Osteoporosis; Ovariec
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; MDD; major depressive disorder; BMD; bone mineral density; SSRI; selective serotonin reuptake inhibitor; BMI; body mass index; OPG; osteoprotegerin; IPAQ; International Physical Activity Questionnaire; CRP; C-reactive protein; IL-6; interleukin-6; RANKL;
Platycarya strobilacea leaf extract inhibits tumor necrosis factor-α production and bone loss induced by Porphyromonas gingivalis-derived lipopolysaccharide
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; LPS; lipopolysaccharide; TNF-α; tumor necrosis factor (TNF)-α; RANKL; receptor activator of nuclear factor-κB ligand; ALP; alkaline phosphatase; M-CSF; macrophage-colony stimulating factor; NFATc1; nuclear factor of activated T cell c1; DC-STAMP; dendr
Combination of 4-hydroperoxy cyclophosphamide and methotrexate inhibits IL-6/sIL-6R-induced RANKL expression in fibroblast-like synoviocytes via suppression of the JAK2/STAT3 and p38MAPK signaling pathway
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; 4-H-CTX; 4-hydroperoxy cyclophosphamide; MTX; methotrexate; CTX; cyclophosphamide; RA; rheumatoid arthritis; FLS; fibroblast-like synoviocytes; RANKL; receptor activator of nuclear factor-κB ligand; JAK2; Janus activated kinase 2; STAT3; signal transduce
Preoperative Cytoreduction of Clival Giant Cell Tumor: An Effective Replication of the Systemic Modality in the Skull Base
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; Denosumab; Giant cell tumors; Skull base; GCT; Giant cell tumor; RANK; Receptor activator of nuclear factor-κB; RANKL; Receptor activator of nuclear factor-κB ligand;
BCAP promotes osteoclast differentiation through regulation of the p38-dependent CREB signaling pathway
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; BCAP; B-cell adaptor for PI3K; PI3K; phosphatidylinositol 3-Kinase; BMM; bone marrow-derived monocyte/macrophage lineage cell; NFATc1; nuclear factor of activated T-cells c1; TRAP; tartrate-resistant acid phosphatase; RANKL; receptor activator of nuclear
BCL3 regulates RANKL-induced osteoclastogenesis by interacting with TRAF6 in bone marrow-derived macrophages
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; TRAF6; tumor necrosis factor receptor-associated factor 6; BCL3; B-cell chronic lymphatic leukemia protein 3; TAK1; transforming growth factor β-activated kinase 1; RANKL; Receptor activator of nuclear factor-κB ligand; NFATC1; nuclear factor of activat
Anti-osteoclastic effect of caffeic acid phenethyl ester in murine macrophages depends upon the suppression of superoxide anion production through the prevention of an active-Nox1 complex formation
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; CAPE; caffeic acid phenethyl ester; RANKL; receptor activator of nuclear factor-κB ligand; TRAP; tartrate-resistant acid phosphatase; ROS; reactive oxygen species; Nox1; NADPH (nicotinamide adenine dinucleotide phosphate) oxidase 1; NF-κB; nuclear facto
Synthesis of novel 5,6-dehydrokawain analogs as osteogenic inducers and their action mechanisms
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; ALP; alkaline phosphatase; αMEM; alpha minimum essential medium; BMP; bone morphogenetic protein; DMSO; dimethyl sulfoxide; HRMS; high-resolution mass spectrometry; MAPK; mitogen-activated protein kinase; ODM; osteoblast differentiation medium; RANKL; re
Ancestral benzo[a]pyrene exposure affects bone integrity in F3 adult fish (Oryzias latipes)
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; AcvR1b; activating receptor type 1b; ALP; alkaline phosphatase; APC; adenomatous polyposis coli; ATF4; activating transcription factor 4; BaP; benzo[a]pyrene; BMD; bone mineral density; BMP2; bone morphogenetic protein 2; Col2a1b; collagen 2a1b; Col10; co
Functions of Rho family of small GTPases and Rho-associated coiled-coil kinases in bone cells during differentiation and mineralization
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; AGC; protein kinase A, G, and C families (PKA, PKC, PKG) of cytoplasmic serine/threonine kinases; AnxA; vertebrate annexin; ALP; alkaline phosphatase; ANK; progressive ankylosis protein; BMP; bone morphogenetic protein; BSP; bone sialoprotein; CHOL; chole
Salicortin inhibits osteoclast differentiation and bone resorption by down-regulating JNK and NF-κB/NFATc1 signaling pathways
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; Salicortin; Osteoclastogenesis; JNK; NF-κB/NFATc1; BMM; bone marrow macrophage; JNK; c-Jun N-terminal kinase; M-CSF; macrophage colony-stimulating factor; NFATc1; nuclear factor of activated T cells c1; RANKL; receptor activator of nuclear factor-κB lig
Diarylheptanoid from Curcuma comosa Roxb. suppresses RANKL-induced osteoclast differentiation by decreasing NFATc1 and c-Fos expression via MAPK pathway
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; Nephthol AS-MX phosphate (PubChem CID: 74136); p-nitrophenyl phosphate (PubChem CID: 468686); Fast red violet LB salt (PubChem CID: 16219357); Toluene blue O (PubChem CID: 7083); sulfanilamide (PubChem CID: 5333); formaldehyde (PubChem CID: 712); Triton X
Case ReportTibial stress reaction presenting as bilateral shin pain in a man taking denosumab for giant cell tumor of the bone
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; MRI; magnetic resonance imaging; FDA; Food and Drug Administration; AFF; atypical femoral fractures; RANKL; receptor activator of nuclear factor-κB ligand; Denosumab; Stress reaction; Atypical femoral fractures; Osteoporosis;
Overexpression of Arl6ip5 in osteoblast regulates RANKL subcellualr localization
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; RANKL; Subcellular trafficking; Osteoclastogenesis; Arl6ip5; ADP-ribosylation-like factor 6 interacting protein 5; ER; endoplasmic reticulum; HA; hemagglutin; OPG; Osteoprotegerin; POBs; Primary osteoblasts; RANKL; receptor activator of nuclear factor-κB
Ginkgo biloba extract promotes osteogenic differentiation of human bone marrow mesenchymal stem cells in a pathway involving Wnt/β-catenin signaling
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; GBE; Ginkgo biloba extract; BM-MSCs; bone marrow derived mesenchymal stem cells; ALP; alkaline phosphatase; OPG; osteoprotegerin; RANKL; receptor activator of nuclear factor-κB ligand; BMP4; bone morphogenetic protein 4; Ginkgo biloba extract (GBE); Oste
Scoparone attenuates RANKL-induced osteoclastic differentiation through controlling reactive oxygen species production and scavenging
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; TRAP; tartrate-resistant acid phosphatase; RANKL; receptor activator of nuclear factor-κB ligand; ROS; reactive oxygen species; Nox1; NADPH (nicotinamide adenine dinucleotide phosphate) oxidase 1; SOD 1; superoxide dismutase 1; CAT; catalase; NFATc1; nuc
Inhibitory effects of ursolic acid on osteoclastogenesis and titanium particle-induced osteolysis are mediated primarily via suppression of NF-κB signaling
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; Ursolic acid; Osteoclastogenesis; NF-κB; Titanium particle; Osteolysis; AP-1; activator protein-1; BV/TV; bone volume/tissue volume; BMD; bone mineral density; BMC; bone mineral content; BMMs; bone marrow monocytes; CK; cathepsin K; CT; computed tomograp
A novel microRNA regulates osteoclast differentiation via targeting protein inhibitor of activated STAT3 (PIAS3)
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; miRNAs; microRNAs; PIAS3; protein inhibitor of activated STAT3; M-CSF; macrophage colony stimulating factor; RANKL; receptor activator of nuclear factor-κB ligand; RANK; receptor activator of NF-κB; OPG; osteoprotegerin; MAPKs; mitogen-activated protein
Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; Atrial fibrillation; Osteoprotegerin; Receptor activator of nuclear factor-κB; Receptor activator of nuclear factor-κB ligand; Atrial remodeling;
Odontoblast-like MDPC-23 cells function as odontoclasts with RANKL/M-CSF induction
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; RANKL, Rankl; receptor activator of nuclear factor-κB ligand; RANK, Rank; receptor activator of nuclear factor-κB; M-CSF, M-csf; macrophage colony stimulating factor; MITF, Mitf; microphthalmia-associated transcription factor; OSTM1, Ostm1; osteopetrosi
Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; BPs; bisphosphonates; ZOL; zoledronate; RANKL; receptor activator of nuclear factor-κB ligand; NTx; N-terminal telopeptide; CATK; cathepsin K; OPG; osteoprotegerin; PTHrP; parathyroid hormone-related peptide; M-CSF; macrophage colony-stimulating factor;
Homocysteine alters the osteoprotegerin/RANKL system in the osteoblast to promote bone loss: pivotal role of the redox regulator forkhead O1
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; RANKL; receptor activator of nuclear factor-κB ligand; sRANKL; secretory RANKL; RANK; receptor activator of nuclear factor-κB; OPG; osteoprotegerin; OVX; ovariectomized; NAC; N-acetylcysteine; ROS; reactive oxygen species; FOXO; forkhead O; JNK; c-Jun N
Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; ISL; isoliquiritigenin; BMMs; bone marrow-derived macrophages; RANKL; receptor activator of nuclear factor-κB ligand; M-CSF; macrophage colony-stimulating factor; TRAF6; tumor necrosis factor receptor - associated factor 6; MAPK; mitogen-activated prot
Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; BMD; bone mineral density; BMI; body mass index; GWAS; genome-wide association study; LD; linkage disequilibrium; LRP5; low-density lipoprotein receptor-related protein 5; OPG; osteoprotegerin; RANK; receptor activator of nuclear factor-κB; RANKL; recept
Adrm1 interacts with Atp6v0d2 and regulates osteoclast differentiation
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; Adrm1; adhesion-regulating molecule 1 protein; Atp6v0d2; d2 subunit of the vacuolar (H+) ATPase V0 domain; RANKL; receptor activator of nuclear factor-κB ligand; M-CSF; macrophage-colony stimulating factor; Osteoclast; Atp6v0d2; Adrm1; Cell fusion; Diffe
RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; BMP receptor-IB; BMP-2; RNA interference; Bone cells; BMP; bone morphogenetic proteins; BMPR; bone morphogenetic protein receptor; TGF-β; transforming growth factor β; ALP; alkaline phosphatase; Col I; type-I collagen; OP; osteopontin; BSP; bone sialopr
Licochalcone A inhibits the formation and bone resorptive activity of osteoclasts
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; Licochalcone A; Osteoclast formation; Bone resorption; ERK; NF-κB; Fra-2; AP; activator protein; ATP6v0d2; v-ATPase V0 subunit d2; BMM; bone marrow-derived macrophage; ERK; extracellular signal-regulated kinase; FBS; fetal bovine serum; GAPDH; glyceralde
Bone loss in children with Crohn disease: Evidence of “osteoimmune” alterations
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; BMD; Bone mineral density; CD; Crohn disease; DXA; Dual-energy x-ray absorptiometry; IFN; Interferon; OPG; Osteoprotegerin; RANKL; Receptor activator of nuclear factor-κB ligand;
Hypoxic stress enhances osteoclast differentiation via increasing IGF2 production by non-osteoclastic cells
Keywords: گیرنده گیرنده لیگاند فاکتور هسته ای κB; Osteoclast; Hypoxia; Differentiation; Insulin-like growth factor 2; Stromal cell-derived factor 1; Receptor activator of nuclear factor-κB ligand; DNA microarray; Reverse transcription polymerase chain reaction;